Sponsors & CROs

Accelerating Research. Expanding Reach. Elevating Results.

With more than 100 investigators across 18 sites in five states (and growing), our reach is national, our processes are streamlined, and our commitment to your success is absolute.

At NextStage Clinical Research, we provide Sponsors and CROs with what matters most: high-quality data, diverse and engaged patient populations, and a proven ability to deliver results on time – without compromising on safety or integrity.

Get Started Today

Expanding Access. Advancing Care.

Our embedded clinical site network reaches patients where they are, bringing trials closer, faster, and with greater impact.

Feasibility Request

Markets

Research Sites

States

Investigators

… and growing!

Real-World Results Start with Real-World Representation

Access to participants across age, gender, race, ethnicity, socioeconomic status, including communities often missing from research, ensures data reflects real-world populations, giving you accurate, effective, and inclusive science.

CDC-Informed, FDA-Approved Diversity Statistics

  • In 2020, only 8% of trial participants were Black vs. 13% in the U.S. – we’re changing that narrative.
  • Hispanics account for just 11% of trials but nearly 19% of the U.S. – so we built patient pools that finally balance the scales.
  • Across U.S. sites from 2015–19, Black or African American enrollment averaged 16%, Asians just 2% – we go broader, smarter, fairer.
  • In pivotal trials for new molecular entities in 2020, 75% of participants were White; only 8% were Black or African American, 11% Hispanic or Latino, and 6% Asian. (Source: Reuters)
  • A broader 2015–2019 analysis of U.S. trial sites showed 78% White, 16% Black or African American, 2% Asian, ~0.5% American Indian/Alaska Native; Hispanic/Latino accounted for 15%, noting roughly 9% of ethnicity data was missing. (Source: PMC)
  • More recent industry numbers echo those disparities: Black individuals comprise ~8% of trial participants versus 13% in the U.S., and Hispanic/Latino represent 11% versus 19% of the population. (Sourse: contractpharma.com)

Relevant Studies

We provide access to a wide range of specialties, helping you bring your clinical research to the next level. Our national reach includes diverse communities and underrepresented populations.

Cardiology & Vascular

Ophthalmology

Psychiatry/Addiction

Analgesics/Pain

Medical Devices

Metabolic

Nephrology

Orthopedics/Sports

Surgical

Urology

Wound Care

Built Around Your Needs

From outpatient clinics, to full surgical sites, overnight stays, we give you access to sites that align with your needs.

With the experience of our team, you can know your study is in great hands.

  • Specialist-focused, embedded medical network
  • Outpatient and surgical care sites
  • Custom onboarding and training
  • Integrated EDC systems
  • Overnight beds and lab access
  • Access to advanced diagnostics (CT, X-ray, MRI)
  • Centralized coordination for budgets/contracts
  • Access to physical therapy, urgent care, and ICU devices

What You Gain with NextStage

Quality of Data

Dedicated quality assurance team

Centralized Support

  • Clinical Operations for Centralized Support
  • Business Development
  • Feasibility
  • Project Management
  • Budgets and Contracts
  • Regulatory
  • Recruitment
  • Quality Assurance

National Reach & Local Relationships

Access diverse, broad patient pools, including underrepresented populations often missing from research.

Flexibility and Agility at Every Stage

We pivot quickly to address challenges, protect safety, and keep your study moving forward.

Established Collaborators

Established collaborations with top-tier specialists enable NextStage to efficiently operationalize complex trials, both in- and out-patient.

Phase 1–4 Expertise

Collaborations with top-tier specialists ensure scientific rigor and operational excellence.

Purpose Beyond the Protocol

We believe every patient deserves access to innovation, and that diversity in research leads to better science, better medicine, and better outcomes.

Physicians Who Made The Leap

“NCR has engaged PIs who are not only world-class surgeons with very busy clinical practices, but they are best-in-class people who truly care. This is why you are different and this is why we will bring innovation to market faster.”

Chief Medical Officer

Biotech Company

“NCR addresses an unmet need for busy physician practices like mine. We have a large practice, but do not have the resources to do meaningful clinical research to provide innovative solutions to patients across the Central Texas region.”

Dr. Buck Cross

Managing Partner, Waco Cardiology Associates

Partner with NextStage — to Accelerate Your Next Study.

Fill out the form and we’ll follow up with simple next steps.

Name